One week after the last cell transfer, evaluation of tumor size indicated larger tumors in mice receiving Rik-overexpressing CD8+ T cells, compared with tumors in mice receiving control CD8+ T cells (Figure 5A). This evidence concerns the gene CD8A and neoplasm.